期刊文献+

Survivin在非霍奇金淋巴瘤中的表达及意义 被引量:2

Significance and expression of Survivin protein in non-Hodgkin′s lymphoma
下载PDF
导出
摘要 目的:探讨Survivin抗原在非霍奇金淋巴瘤(NHL)中的表达及临床意义。方法:采用免疫组织化学SP方法,检测Survivin在52例NHL及12例淋巴结反应性增生(RH)中的表达情况。结果:Survivin在淋巴结反应性增生中的阳性表达率明显低于NHL,侵袭性NHL表达水平明显高于惰性NHL。Survivin在非霍奇金淋巴瘤的表达与性别、年龄、患者临床分期、有无全身症状、患者淋巴瘤细胞来源、首发部位无关。LDH<250 U/L NHL Survivin阳性表达率明显低于LDH>250 U/L NHL Survivin阳性表达率。Survivin阳性表达率>25%非霍奇金淋巴瘤患者与阳性表达率<25%非霍奇金淋巴瘤患者相比较,平均生存期短。结论:Survivin与NHL的发生发展有关,并可对预后判断提供参考依据。 Objective: To explore the expression of Survivin in non-Hodgkin's lymphoma cells with variable aggressiveness and its clinical significance. Methods: The SP immunohistochemistry staining method was used to detect the expression of Survivin. Results: The positive rate of Survivin in the reactive hyperplasia of the lymph node was lower than that in non-Hodgkin's lymphoma. The positive rate of Survivin was related to the aggressiveness of non-Hodgkin's lymphoma, but it was not related to the sex, age, clinical stage, body symptoms, immunotype and initial organ. Different Survivin expressions were found between different levels of LDH. High Survivin expression was associated with low survival stage. Conclusion: Survivin may play certain roles in the oncogenesis and the progression of non-Hodgkin's lymphoma, and it has positive effects on the prognosis of non-Hodgkin's lymphoma.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第3期283-285,289,共4页 Journal of Shandong University:Health Sciences
关键词 免疫组织化学 淋巴瘤 非霍奇金 SURVIVIN Immunohistochemistry Lymphoma, non-Hodgkin Survivin
  • 相关文献

参考文献12

  • 1Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J].Nat Med,1997,3(8):917-921.
  • 2Sarela AI,Macadam RC.Expression of the anti-apoptosis gene,survivin,predicts death from recurrent colorectal carcinoma[J].Gut,2000,46(5):645-650.
  • 3Ashraful I,Jajime K,Nalyuki T,et al.High expression of survivin,mapped to 17q25,is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma[J].Oncogene,2000,19(5):617-623.
  • 4konno R,yamakawa H,Utsunomiya H,et al.Expression of survivin and bcl-2 in the normal human endometrium[J].Mol Hum Report,2000,6(6):529-534.
  • 5Escuin D,Rosell R.The anti-apoptosis survivin gene and its role in human cancer:an overview[J].Clin Lung Cancer,1999,1(2):138-143.
  • 6Altieri DC.Survivin,versatile modulation of cell division and apoptosis in cancer[J].Oncogene,2003,22(53):8 581-8 589.
  • 7唐文台,郭瑞珍,梁群英,肖庆邦.Survivin在非霍奇金淋巴瘤中的表达及其意义[J].肿瘤防治研究,2004,31(1):39-41. 被引量:3
  • 8李红玲,孙秉中,冯琦,尚振川.Survivin、caspase-3在非霍奇金淋巴瘤组织中的表达及意义[J].癌症,2004,23(1):40-43. 被引量:20
  • 9Morra E.The biological market of non-Hodgkin's lymphomas:their role in diagnosis,prognostic assessment and the rapeutic strategy[J].Int J Biol Markets,1999,14(3):149-153.
  • 10Adida C,Haioun C,Gaulard P,et al.Prognostic significance of survivin expression in diffuse large B-cell lymphoma[J].Blood,2000,96(5):1 921-1 925.

二级参考文献19

  • 1[1]LaCasse EC, Baird S, Korneluk RG, et al. The inhibitors of apoptosis(IAPs) and their emerging role in cancer [J].Oncogene, 1998, 17 (25): 3247 - 3259.
  • 2[2]Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor ofcaspase-3 and-7 [J].Biochemistry, 2001, 40(4): 1117 - 1123.
  • 3[3]Cohen C, Lohmann CM, Cotsonis G, et al. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis [J]. Mod Pathol, 2003, 16(6):574-583.
  • 4[4]Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax, caspases, and anticancer drugs [J] . Cancer Res, 1998,58(23): 5315 -5320.
  • 5[5]Wang CY, Mayo MW, Korneluk RG, et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation [J]. Science, 1998, 281(5383): 1680 - 1683.
  • 6[6]Suzuki A, Ito T, Kawano H, et al. survivininitiates procaspase-3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death [J]. Oncogene,2000, 19 (10): 1346 - 1353.
  • 7[7]Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma [J]. Nat Med,1997, 3(8): 917 -921.
  • 8[8]Kanavaros P, Bai M, Stefanaki K, et al. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67,cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas [J]. Histol Histopathol, 2001, 16(2): 377 -386.
  • 9[9]Jesionek-Kupnicka D, Tenderenda M, Rutkowski P. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features [ J ]. J Exp Clin Cancer Res, 2002, 21 (3): 371 - 375.
  • 10[10]Soini Y, Paakko P. Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas [J]. APMIS, 1999,107(11): 1043 - 1050.

共引文献21

同被引文献28

  • 1黄慧强,彭玉龙,黄欣,潘战和,侯景辉,吴秋良.Survivin在T细胞非霍奇金淋巴瘤组织中的表达及临床意义[J].中山大学学报(医学科学版),2006,27(2):221-224. 被引量:7
  • 2张俊萍,王毓銮.恶性淋巴瘤的生物治疗进展[J].白血病.淋巴瘤,2006,15(6):474-476. 被引量:7
  • 3史周印,张明智,李道明,高冬玲,庞霞.非霍奇金淋巴瘤组织中Survivin的表达及细胞凋亡检测[J].郑州大学学报(医学版),2007,42(1):151-154. 被引量:2
  • 4Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas[J]. Blood,2000,96 : 1921-1925.
  • 5Davis ID, Skak K, Smyth MJ, et al. Interleukin-21 signaling: functions in cancer and autoimmunity [ J ]. Clin Cancer Res ,2007,13 (23) :6926-6932.
  • 6Jin H, Carrio R, Yu A, et al. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim- dependent apoptosis [J]. The Journal of Immunology,2004,173 ( 1 ):657-665.
  • 7Parrish-Novak J, Foster DC, Holly RD, et al. Interleukin- 21 and the IL-21receptor: novel effectors of NK and T cell responses [ J ]. Leukoc Biol,2002,72 ( 5 ) : 856-863.
  • 8Wang G, Tschoi M, Spolski R, et al. In Vivo Antitumor Activity of Interleukin 21 Mediated by Natural Killer Cells [ J ]. Cancer Res, 2003,63 ( 24 ) :9016-9022.
  • 9Kawasaki H, Altiefi DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in eoloreetal cancer[ J ]. Cancer Res, 1998,58 ( 22 ) :5071-5074.
  • 10Das A, Tan WL, Teo J, et al. Expression of survivin in primary glioblastomas[ J]. J Cancer Res Clin Oncol,2002, 128 (6):302-306.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部